Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 1
2006 1
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2015 1
2016 2
2018 1
2019 4
2020 3
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Antiangiogenic metronomic chemotherapy.
Sarmiento R, Gasparini G. Sarmiento R, et al. Onkologie. 2008 Apr;31(4):161-2. doi: 10.1159/000119925. Epub 2008 Mar 20. Onkologie. 2008. PMID: 18418015 Free article. No abstract available.
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
Verzeroli C, Giaccherini C, Russo L, Bolognini S, Gamba S, Tartari CJ, Schieppati F, Ticozzi C, Vignoli A, Masci G, Sarmiento R, Spinelli D, Malighetti P, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Gasparini G, Minelli M, De Braud F, Santoro A, Labianca R, Marchetti M, Falanga A; HYPERCAN Investigators. Verzeroli C, et al. Among authors: sarmiento r. J Thromb Haemost. 2023 Jul;21(7):1869-1881. doi: 10.1016/j.jtha.2023.03.037. Epub 2023 Apr 11. J Thromb Haemost. 2023. PMID: 37054917 Free article.
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Gomez-Rosas P, Giaccherini C, Russo L, Verzeroli C, Gamba S, Tartari CJ, Bolognini S, Ticozzi C, Schieppati F, Barcella L, Sarmiento R, Masci G, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Minelli M, De Braud F, Santoro A, Labianca R, Gasparini G, Marchetti M, Falanga A, On Behalf Of The Hypercan Investigators. Gomez-Rosas P, et al. Among authors: sarmiento r. Cancers (Basel). 2023 Sep 15;15(18):4588. doi: 10.3390/cancers15184588. Cancers (Basel). 2023. PMID: 37760562 Free PMC article.
Thalidomide: a new anticancer drug?
Fanelli M, Sarmiento R, Gattuso D, Carillio G, Capaccetti B, Vacca A, Roccaro AM, Gasparini G. Fanelli M, et al. Among authors: sarmiento r. Expert Opin Investig Drugs. 2003 Jul;12(7):1211-25. doi: 10.1517/13543784.12.7.1211. Expert Opin Investig Drugs. 2003. PMID: 12831355 Review.
Anti-angiogenic and anti-HER therapy.
Gasparini G, Sarmiento R, Longo R. Gasparini G, et al. Among authors: sarmiento r. Biomed Pharmacother. 2006 Jul;60(6):263-5. doi: 10.1016/j.biopha.2006.06.001. Epub 2006 Jun 23. Biomed Pharmacother. 2006. PMID: 16815667 Review.
Prognostic and predictive indicators in operable breast cancer.
Morabito A, Magnani E, Gion M, Sarmiento R, Capaccetti B, Longo R, Gattuso D, Gasparini G. Morabito A, et al. Among authors: sarmiento r. Clin Breast Cancer. 2003 Feb;3(6):381-90. doi: 10.3816/CBC.2003.n.002. Clin Breast Cancer. 2003. PMID: 12636883 Review.
Antiangiogenic agents.
Stani SC, Capaccetti B, Bonginelli P, Sarmiento R, De Sio L, Fanelli M, Gasparini G. Stani SC, et al. Among authors: sarmiento r. Suppl Tumori. 2002 Jul-Aug;1(4):S39-43. Suppl Tumori. 2002. PMID: 12415816 Review. No abstract available.
27 results